丽珠肠乐思密达治疗小儿腹泻疗效观察

Observation of curative effect of Bifidobiogen and Smicta curing infantile diarrhoea

目的:观察丽珠肠乐加思密达治疗小儿腹泻疗效。方法:治疗组口服丽珠肠乐加思密达,对照组只服或不服丽珠肠乐或思密达,各组均采用相同的基础治疗。比较各组症状、体征缓解的差异及有效率。结果:治疗组临床症状、体征缓解时间较对照Ⅲ组缩短(P<0.01),与对照Ⅱ组在退热时间上有差异(P<0.05),与对照Ⅰ组、对照Ⅱ组在止泻、止吐上无差异。结论:丽珠肠乐加思密达治疗小儿腹泻的方法值得推广。

Objective: Observing the curative effect of Bifidobiogen and Smicta in curing infantile diarrhoea. Method: The treating group took Bifidobiogen and Smicta. The control groups only took or did not take Bifidobiogen or Smicta. They all use the same basic remedy. The treating conditions, difference of body improvement and their efficiency were compareed between these groups. Results: The duration of clinical condition and the body improvement were shorter than those of the contrast group Ⅲ. The time is different in reducing fever and there is no difference in sloping diarrhoea and throwing up in comparision with group Ⅰ and group Ⅱ. Conclusion: Bifidobigen and Smicta are worth popularizing in curing infantile diarrhoea.